Related Experiment Video
Updated: May 21, 2026

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
Published on: January 28, 2020
Carbohydrate antigen 125: a new biomarker in heart failure
Enrico Vizzardi1, Antonio D'Aloia, Antonio Curnis
1Applied and Experimental Medicine Department, Department of Cardiology, University of Brescia, Brescia, Italy. enrico.vizzardi@tin.it
Abstract:
Tumor markers are used for the screening, diagnosis, and stratification of cancer disease, but recently the role of some tumor markers has also been explored in the context of patients with heart failure (HF). Of all tumor biomarkers, carbohydrate antigen-125 (CA-125) has emerged as a potential biomarker in HF by showing correlations with clinical, hemodynamic, and echocardiographic parameters indicative of the severity of the disease. Interestingly, fluctuations in serum levels of CA-125 after treatment were also found, suggesting potential utility in a serial and long-term therapeutic intervention assessment. It has also been reported that in patients with HF, there is a significant correlation between CA-125 and brain natriuretic peptide levels. The aim of this article is to review the data currently available on serum levels of tumor markers in patients with chronic HF, focusing attention on the potential clinical use of CA-125.
Related Concept Videos
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Heart Failure II: Pathophysiology
Heart Failure IV: Classification and Diagnostic Evaluation
Cardiomyopathy II: Dilated Cardiomyopathy
Acute Coronary Syndrome III: Diagnostic Studies
